Stereotaxis Inc Stock Other OTC
Stocks
US85916J4094
Advanced Medical Equipment & Technology
| Market Cap | 175M 153M 140M 131M 248M 16.66B 252M 1.69B 655M 8.17B 657M 643M 28.15B | P/E 2026 * |
-8.95x | P/E 2027 * | -11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 175M 153M 140M 131M 248M 16.66B 252M 1.69B 655M 8.17B 657M 643M 28.15B | EV / Sales 2026 * |
4.44x | EV / Sales 2027 * | 3.28x |
| Free-Float |
84.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Stereotaxis Inc
| 1 day | -5.62% |
| Manager | Title | Age | Since |
|---|---|---|---|
David Fischel
CEO | Chief Executive Officer | - | 03/02/2017 |
Kimberly Peery
DFI | Director of Finance/CFO | 57 | 01/10/2019 |
Keith Galloway
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Benfer
BRD | Director/Board Member | 79 | 01/02/2005 |
David Fischel
CHM | Chairman | - | 03/02/2017 |
Arun Menawat
BRD | Director/Board Member | 71 | 29/09/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.62% | +10.41% | - | - | 175M | |
| +1.97% | +3.50% | +22.37% | +0.32% | 195B | |
| +5.87% | +6.59% | -21.20% | +24.59% | 151B | |
| +2.17% | +2.44% | -2.26% | -17.53% | 140B | |
| +4.83% | +2.13% | -56.44% | -16.55% | 67.09B | |
| +2.59% | +5.18% | +22.53% | +0.04% | 54.34B | |
| -0.53% | +1.90% | -25.70% | -31.20% | 44.64B | |
| -2.02% | -3.56% | +8.31% | +8.68% | 36.91B | |
| +0.31% | +0.64% | +7.78% | +42.30% | 37.24B | |
| +1.09% | +0.96% | -13.87% | -19.29% | 29.82B | |
| Average | +0.51% | +2.18% | -6.50% | -0.96% | 83.95B | |
| Weighted average by Cap. | +1.50% | +3.35% | -3.56% | +0.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 39.4M 34.43M 31.61M 29.48M 55.89M 3.75B 56.83M 381M 148M 1.84B 148M 145M 6.34B | 53.28M 46.55M 42.75M 39.86M 75.57M 5.07B 76.85M 515M 199M 2.49B 200M 196M 8.57B |
| Net income | -19.4M -16.95M -15.57M -14.52M -27.52M -1.85B -27.98M -187M -72.64M -906M -72.84M -71.26M -3.12B | -13.62M -11.91M -10.93M -10.2M -19.33M -1.3B -19.65M -132M -51.01M -636M -51.16M -50.05M -2.19B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
